1. Home
  2. TRX vs PRQR Comparison

TRX vs PRQR Comparison

Compare TRX & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TRX Gold Corporation

TRX

TRX Gold Corporation

HOLD

Current Price

$1.13

Market Cap

253.9M

Sector

N/A

ML Signal

HOLD

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$2.25

Market Cap

262.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRX
PRQR
Founded
1990
2012
Country
Canada
Netherlands
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
253.9M
262.5M
IPO Year
2002
2014

Fundamental Metrics

Financial Performance
Metric
TRX
PRQR
Price
$1.13
$2.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$1.70
$7.25
AVG Volume (30 Days)
2.4M
794.3K
Earning Date
04-15-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$84.84
N/A
Revenue Next Year
$96.90
$13.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$1.33
52 Week High
$2.80
$3.10

Technical Indicators

Market Signals
Indicator
TRX
PRQR
Relative Strength Index (RSI) 64.97 69.67
Support Level $1.04 $1.94
Resistance Level $1.34 $2.33
Average True Range (ATR) 0.07 0.12
MACD 0.02 0.03
Stochastic Oscillator 87.44 95.61

Price Performance

Historical Comparison
TRX
PRQR

About TRX TRX Gold Corporation

TRX Gold Corp is a high-margin and growing gold company advancing the Buckreef Gold Project in Tanzania. Buckreef Gold includes an established open-pit operation and approximately 2,000 tonnes per day process plant with upside potential demonstrated. The group is focused on creating both near-term and long-term shareholder value by increasing gold production to generate positive cash flow to fund the expansion as outlined in the PEA and grow Mineral Resources through exploration. TRX Gold's actions are led by the highest environmental, social, and corporate governance (ESG) standards, evidenced by the relationships and programs that the Company has developed during its nearly two decades of presence in the Geita Region, Tanzania.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

Share on Social Networks: